Search PubMed⌕ Search

Biomedical subjects

G Karliczek

Publications and source records attributed to G Karliczek.

At least 19 recordsLinked to original sources

Postbypass hypothermia and its relationship to the energy balance of cardiopulmonary bypass.

Using a newly developed computerized intraoperative data acquisition system, the apparent adequacy of rewarming and its relation to the energy exchange between the patient and the bypass system was investigated. Retrospective analysis of comparable patients identified two groups that had, at the end of surgery, either a nasopharyngeal temperature (NPT) of 36 degrees C or more ("warm" group, n = 19), or a NPT of 35 degrees C or less ("cold" group, n = 19). Temperatures from the nasopharynx, thenar eminence skin, and bypass pump arterial and venous lines were continually recorded and sent to the computer data base together with the pump flow rate. There were no significant differences between the groups regarding time on perfusion, time taken to cool, time of hypothermia, or the time interval from end of perfusion to the end of surgery. However, rewarming time was greater in the warm group (P less than 0.01). The cold group were subjected to more profound hypothermia (P less than 0.001), and had lower NPTs and skin temperatures at the end of bypass (P less than 0.0001 and P less than 0.01, respectively). However, the difference between NPT and thenar skin temperature in each group at either the end of bypass or the end of surgery was the same. The net energy exchange between patient and pump was significantly different (mean in warm, 130 kJ [SD = 530]; in cold, -389 kJ [SD = 427]; P less than 0.003). In conclusion, the adequacy of rewarming can be expressed in terms of the energy exchanged in the bypass system, and cannot be assessed by the nasopharynx:skin temperature gradient.

Anesthesia, Intravenous↗

Effects of dexamethason on the early postoperative course after coronary artery bypass surgery.

The effects of dexamethason (DM) on the postoperative course of coronary artery bypass have been investigated in a double blind study. Twenty patients receiving dexamethason 1 mg/kg body weight intravenously (IV) before cardiopulmonary bypass are compared with a control group of 20 patients receiving placebo. In the treated group core temperature remained normal (maximum 37.6 +/- 0.5 degrees C) while in the control group the patients regularly developed fever (39.0 +/- 0.7 degrees C; p less than 0.01). In the DM-treated group a significantly higher blood pressure, and a lower incidence of rhythm disorders were found. There was a marked difference in the fluid requirements between the 2 groups. Without DM the fluid balance was 2,300 cc positive at the end of the study, in the treatment group this excess was only 1,000 cc (p less than 0.001). Dexamethason treatment also led to higher urine output (130 cc/hr, vs. 85 cc/hr). Although the arterial oxygen tension was higher in the treated group, no patient developed respiratory insufficiency in the control group. The post-pump syndrome is re-evaluated and possible mechanisms are discussed.

Blood Pressure↗

Hemodynamic side effects of prostaglandin E1 in patients before and during cardiopulmonary bypass.

Animal experiments have shown that the administration of prostaglandin E1 (PGE1) during cardiopulmonary bypass (CPB) reduces platelet damage and the tendency to bleeding disorders. Because PGE1 also has a strong vasodilating action, a clinical trial was started to evaluate its hemodynamic side-effects. PGE1 was studied during 3 different periods: 1. a 10-minute period before bypass, 2. a hemodynamically stable period during CPB, 3. during the whole period of CPB. 1. Before CPB, a consistent fall of mean arterial pressure (MAP) was observed (26 mmHg). 2. During the stable period of CPB, the blood pressure fall was dependent on the pre-existing systemic vascular resistance. 3. PGE1 infusion during the whole CPB period was, in general, badly tolerated. Increased perfusion flow was not sufficient to compensate for the resulting blood pressure drop. In most of the 13 cases vasopressors had to be given continuously. In 7 patients PGE1 had to be reduced, and in 4 patients the infusion had to be stopped altogether. Because of the marked vasodilator effects of PGE1 it appears impossible to give patients doses adequate to achieve platelet preservation during clinical CPB with safety.

Adult↗

Termination of anaesthesia--do we pay enough attention to its consequences? Haemodynamic studies following the use of piritramide, flunitrazepam and nitrous oxide anaesthesia for open heart surgery.

After completion of coronary or valve replacement surgery the haemodynamic changes due to cessation of nitrous oxide were measured. Seventy-four patients received piritramide-nitrous oxide anaesthesia. In 20 patients nitrous oxide was continued after operation and no marked haemodynamic changes occurred. However, when nitrous oxide was discontinued immediately after the operation (n=30) a significant rise in systolic arterial pressure (108+/-15 to 153+/-30 mm Hg), systolic pulmonary artery pressure (35+/-9 to 40+/-16 mm Hg), systemic vascular resistance (111 +/-26 to 148+/-44 MN.s.m-5) and rate pressure product (9,600+/-1,600 to 14,300+/-4,000) occurred. Heart rate (89+/-11 min-1), left artrial pressure (13+/---4 mm Hg) CO2 minute production (125+/-19 ml. min-1.m-2) and cardiac index (2.5+/-0.61.min-1.m-2) rose only moderately. When additional flunisternal closure to 24 patients, marked haemodynamic changes were still noted after N2O withdrawal, even though anaesthesia was prolonged. The sudden rise of arterial pressure and vascular resistance implies risks to patients with myoicardial or coronary insufficiency, therefore close monitoring is necessary, when nitrous oxide has to be stopped, to enable undelayed antihypertensive therapy.

Adult↗

Changes in hemodynamic parameters, inotropic state, and myocardial oxygen consumption owing to intravenous application of nitroglycerin.

Changes in hemodynamics, inotropic state, and myocardial oxygen consumptom were investigated in a total of 70 patients with coronary disease after intravenous application of nitroglycerin (0.4 mg., 0.2 mg., and 2 mg. per hour). The results demonstrate that nitroglycerin enlarges therapeutic possibilities during and immediately after operations in patients with limited coronary reserve. The decrease in myocardial oxygen consumption, dependent on dose, ranged between 15.8 and 22.9 per cent.

Adult↗